Induction Immunosuppression Improves Long-Term Graft and Patient Outcome in Organ Transplantation: An Analysis of United Network for Organ Sharing Registry Data

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Transplantation

• Publication date

  2010-12-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/TP.0b013e3181fecfcbPMID 21057388
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of Alemtuzumab in Organ Transplantation

  2012cited by this paper
• Daclizumab

  2012cited by this paper
• New directions for induction immunosuppression strategy in solid organ transplantation.

  2009influential reference
• New trends in transplantation: the use of Thymoglobulin®

  2009cited by this paper
• Induction Immunosuppression

  2006influential reference
• The evolving role of alemtuzumab (Campath‐1H) for immunosuppressive therapy in organ transplantation

  2006cited by this paper
• Alemtuzumab (Campath-1H): A Systematic Review in Organ Transplantation

  2006cited by this paper
• Humoral theory of transplantation: mechanism, prevention, and treatment.

  2005cited by this paper
• Homeostatic proliferation is a barrier to transplantation tolerance

  2004cited by this paper
• Impact of Acute Rejection Episodes on Long‐Term Graft Survival Following Simultaneous Kidney‐Pancreas Transplantation

  2003cited by this paper
• The use of basiliximab in solid organ transplantation

  2002cited by this paper
• Impact of delayed graft function and acute rejection on graft survival.

  2002cited by this paper
• Use of basiliximab and daclizumab in kidney transplantation.

  2001cited by this paper
• Impact of delayed graft function and acute rejection on kidney graft survival.

  2000cited by this paper
• Daclizumab: a review of its use in the prevention of acute rejection in renal transplant recipients.

  1999cited by this paper
• The effect of acute rejection on long‐term renal graft survival is mainly related to initial renal damage

  1998cited by this paper
• Renal graft survival in children with early acute rejection.

  1998cited by this paper
• Primate renal transplants using immunotoxin.

  1998cited by this paper
• Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients.

  1998cited by this paper
• Effect of anti-lymphocyte induction therapy on renal allograft survival: a meta-analysis.

  1997cited by this paper
• FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts.

  1997cited by this paper

• The risk of kidney transplant graft loss in sensitized vs. unsensitized patients is modified by prior transplant status.

  2026cites this paper
• Rabbit-Derived Antithymocyte Globulin-Associated Perioperative Anaphylaxis in Renal Transplantation: A Multidisciplinary Perspective on Pathophysiology, Clinical Presentation, and Management

  2025cites this paper
• Complications Associated with Immunosuppressive Agents in Solid Organ Transplant Recipients: A Nationwide Analysis

  2025influential citation
• Inefficiency Rates of Biological Immunosuppressive Induction Agents Used in Organ Transplantation: A Pharmacovigilance Study

  2025cites this paper
• Efficacy and Safety of Induction Therapy in Kidney Transplant Recipients: A Propensity Score Matching Analysis in a Multicenter Retrospective Observational Study.

  2025cites this paper
• Antibody-Mediated Rejection in Liver Transplantation: Immuno-Pathological Characteristics and Long-Term Follow-Up

  2024cites this paper
• Induction Therapies Determine the Distribution of Perforin and Granzyme B Transcripts in Kidney Transplant Recipients

  2024cites this paper
• Significant Increase in Cytomegalovirus (CMV) Infection in Solid Organ Transplants Associated With Increased Use of Thymoglobulin as Induction Therapy?

  2023cites this paper
• Nanoparticle-Based Interventions for Liver Transplantation

  2023cites this paper
• LONG TERM FUNCTIONAL GRAFT SURVIVAL RESULTS OF THE 3RD STAGE SINGLE CENTRE LIVING AND CADAVERIC DONOR TRANSPLANTS.

  2023cites this paper
• Chronic Kidney Disease After Liver Transplantation.

  2023cites this paper
• Current Use of Immunosuppression in Liver Transplantation.

  2023cites this paper
• Induction Therapy in the Current Immunosuppressive Therapy

  2023cites this paper
• Disparities in Transplant Interventions.

  2023cites this paper
• Outcome of Renal Transplantation in Children Given Rabbit Anti-Thymocyte Globulin (rATG) as Induction Therapy.

  2022cites this paper
• The optimal immunosuppression management to prevent early rejection after liver transplantation: A systematic review of the literature and expert panel recommendations

  2022cites this paper
• Recomendaciones para el trasplante renal de donante vivo

  2022cites this paper
• Recommendations for living donor kidney transplantation.

  2022cites this paper
• [Update: Immunosuppression in organ transplantation].

  2022cites this paper
• Immunosuppression and Heart Transplantation.

  2021cites this paper
• Renal function after liver transplantation: Real-world experience with basiliximab induction and delayed reduced-dose tacrolimus.

  2021cites this paper
• Comparison of induction therapy with anti-thymocyte/antilymphocyte globulin or anti-IL-2 receptor antibody in pediatric kidney transplantation: a systematic review and meta-analysis

  2021cites this paper
• The Management of Immunosuppression in Kidney Transplant Recipients with COVID-19 Disease: An Update and Systematic Review of the Literature

  2021cites this paper
• Impact of induction therapy on outcomes after heart transplantation

  2021cites this paper
• Basiliximab Induction with Delayed Calcineurin Inhibitors for High-Risk Lung Transplant Candidates.

  2021cites this paper
• Induction and Donor Specific Antibodies in Low Immunologic Risk Kidney Transplant Recipients.

  2020cites this paper
• Update: Immunsuppression bei Organtransplantationen

  2020cites this paper
• Immunosuppression in liver transplant.

  2020cites this paper
• Induction immunosuppression and the risk of incident malignancies among older and younger kidney transplant recipients: A prospective cohort study

  2020cites this paper
• Mechanisms and clinical applications of immunosuppressive medications

  2020influential citation
• Dual Induction Therapy after Pediatric Kidney Transplantation in a Multiracial Cohort: A Single Center Experience

  2020cites this paper
• Immunosuppressive strategies in lung transplantation

  2020cites this paper
• Immunology in Tumor and Transplant

  2020cites this paper
• Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients

  2020cites this paper
• Induction therapy with thymoglobulin or interleukin-2 receptor antagonist for Chinese recipients of living donor renal transplantation: a retrospective study

  2019cites this paper
• Alemtuzumab Induction Reduces Early Rejection in Female Renal Allograft Recipients: A Single Center Study.

  2019cites this paper
• Interleukin-27 promotes CD8+ T cell reconstitution following antibody-mediated lymphoablation.

  2019cites this paper
• Impact of induction immunosuppression on patient survival in heart transplant recipients treated with tacrolimus and mycophenolic acid in the current allocation era

  2019cites this paper
• Immunosuppression in Pediatric Liver Transplant

  2019cites this paper
• Vasculogenically conditioned peripheral blood mononuclear cells inhibit mouse immune response to induced pluripotent stem cell-derived allogeneic cardiac grafts

  2019cites this paper
• Effectiveness of Antithymocyte Globulin Induction Dosing Regimens in Kidney Transplantation Patients: A Network Meta-analysis.

  2019cites this paper
• La terapia immunosoppressiva nel trapianto di rene

  2019cites this paper
• Immunosuppression after renal transplantation

  2019cites this paper
• Immune Tolerance and Rejection in Organ Transplantation.

  2019cites this paper
• The use of induction therapy in liver transplantation is highly variable and is associated with posttransplant outcomes

  2019cites this paper
• Infections in Kidney and Pancreas Transplantation

  2019cites this paper
• A Critical Appraisal of the Possible Use of Induction Agents in Low Risk Kidney Transplant Recipients : A Nigerian Perspective

  2019cites this paper
• Induction Therapy With ATG Compared With Anti-IL2 Basiliximab in Low-Immunologic Risk Kidney Transplant Recipients.

  2019cites this paper
• Alemtuzumab Induction Is Associated With an Equalization of Outcomes Between White and African American Kidney Transplant Recipients.

  2019cites this paper
• Kidney transplant outcomes in HIV-positive patients: a systematic review and meta-analysis

  2019cites this paper
• Immunological Tolerance

  2019cites this paper
• Intraoperative and Early Postoperative Management of Heart Transplantation: Anesthetic Implications.

  2019cites this paper
• Induction regimen and survival in simultaneous heart-kidney transplant recipients.

  2018cites this paper
• Induction immunosuppression agents as risk factors for incident cardiovascular events and mortality after kidney transplantation

  2018cites this paper
• Induction immunosuppressive therapy in cardiac transplantation: a systematic review and meta-analysis

  2018cites this paper
• Renal Transplantation in Second-Level Private Hospitals in the State of Mexico.

  2018cites this paper
• Use of ATG-Fresenius as an Induction Agent in Deceased-Donor Kidney Transplantation.

  2017cites this paper
• Equine Anti-Thymocyte Globulin (ATGAM) administration in patient with previous rabbit Anti-Thymocyte Globulin (Thymoglobulin) induced serum sickness: A case report

  2017cites this paper
• Cytokine Biomarkers of Disease Activity and Therapeutic Response after Initiating Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis

  2017cites this paper
• Effectiveness of an Evidence‐Based Induction Therapy Protocol Revision in Adult Kidney Transplant Recipients

  2017cites this paper
• Tailor-Made Induction Therapy in ‘Low Risk’ Renal Transplants; A South Asian Perspective

  2017cites this paper
• Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation.

  2017cites this paper
• Outcomes of Early Steroid Withdrawal in Recipients of Deceased-Donor Expanded Criteria Kidney Transplants in the Era of Induction Therapy.

  2016cites this paper
• Immunosuppressive Therapy in Transplantation.

  2016cites this paper
• Current techniques for AB0-incompatible living donor liver transplantation

  2016cites this paper
• The Impact of Alemtuzumab and Basiliximab Induction on Patient Survival and Time to Bronchiolitis Obliterans Syndrome in Double Lung Transplantation Recipients

  2016cites this paper
• Immunosuppression: Induction, Maintenance, and Steroid Avoidance Protocols

  2016cites this paper
• Basiliximab versus rabbit antithymocyte globulin as induction therapy for living-related renal transplantation: a single-center experience

  2016cites this paper
• Immunosuppression in Solid-Organ Transplantation: Essentials and Practical Tips

  2016cites this paper
• Obliterative Bronchiolitis

  2016cites this paper
• Evolution of Immunosuppressive Agents in Renal Transplantation: An Updated Review

  2016cites this paper
• Challenging immunosuppression treatment in lung transplant recipients with kidney failure.

  2016cites this paper
• [Immunology and immunosuppression in kidney transplantation. ABO and HLA incompatible kidney transplantation].

  2016cites this paper
• Induction Immunosuppression and Clinical Outcomes in Kidney Transplant Recipients Infected With Human Immunodeficiency Virus

  2016cites this paper
• Induction Agent in Low Immunological Risk; the Indian Scenario

  2016cites this paper
• The search for the optimal antibody induction strategy in kidney transplantation: still “hazy” after all these years

  2015cites this paper
• Immunosuppressive Biologic Agents

  2015cites this paper
• Current State of Immunosuppression: Past, Present, and Future.

  2015cites this paper
• Metabolic outcomes of islet transplantation and correlation of graft function with hepatic imaging and immune response

  2015cites this paper
• High Ficolin-3 Level at the Time of Transplantation Is an Independent Risk Factor for Graft Loss in Kidney Transplant Recipients

  2015cites this paper
• Update: Immunsuppression bei Organtransplantationen

  2015cites this paper
• Survival benefit of induction immunosuppression in cystic fibrosis lung transplant recipients.

  2015cites this paper
• Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression

  2015cites this paper
• Lymphocytes as an Indicator for Initial Kidney Function: A Single Center Analysis of Outcome after Alemtuzumab or Basiliximab Induction

  2015cites this paper
• Kinetics of B, T, NK lymphocytes and isoagglutinin titers in ABO incompatible living donor liver transplantation using rituximab and basiliximab.

  2015cites this paper
• Comparison of alemtuzumab vs. antithymocyte globulin induction therapy in primary non‐sensitized renal transplant patients treated with rapid steroid withdrawal

  2015cites this paper
• Trasplante de células madre mesenquimales en un modelo de rechazo crónico del injerto pulmonar

  2015cites this paper
• Impact of induction immunosuppression on survival in heart transplant recipients: a contemporary analysis of agents

  2015cites this paper
• Changes in frequency of delayed graft function in deceased donor renal transplant recipient in a tertiary care center in Mexico.

  2015cites this paper
• Outcome and Cost Analysis of Induction Immunosuppression With IL2Mab or ATG in DCD Kidney Transplants

  2014cites this paper
• Induction Therapy in Renal Transplant Recipients: A Review

  2014cites this paper
• Current strategies for immunosuppression following liver transplantation

  2014cites this paper
• Current challenges in liver transplantation for hepatocellular carcinoma.

  2014cites this paper
• Critical Role of Sensitized Serum in Rejection of Allogeneic Bone Marrow Cells

  2014cites this paper
• Three‐yr safety and efficacy of everolimus and low‐dose cyclosporine in de novo pediatric kidney transplant patients

  2014cites this paper
• Impact of steroid maintenance on the outcomes in first-time deceased donor kidney transplant recipients: Analysis by induction type.

  2014cites this paper
• Monoclonal Antibody Therapy and Renal Transplantation: Focus on Adverse Effects

  2014cites this paper
• Erratum to: New Directions for Rabbit Antithymocyte Globulin (Thymoglobulin®) in Solid Organ Transplants, Stem Cell Transplants and Autoimmunity

  2014cites this paper
• A retrospective study of cytomegalovirus pneumonia in renal transplant patients

  2014cites this paper
• An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome

  2014cites this paper